Nevertheless, certain research has reported an increase in CD3 + CD56 + cells (NKTs) in the livers of MASLD/MASH patients, primarily through immunohistochemical analysis [38, 56, 57]. The gene discussed is NCAM1; the disease is metabolic dysfunction-associated steatotic liver disease.